Nephrology, Dialysis, Transplantation

Individualizing pharmacologic and non-pharmacologic therapy for CKD associated with diabetes

By Zurong Zhang, Li Li, Ming Yang, Rajiv Agarwal

ReviewInterventions

The paper

Zurong Zhang, Li Li, Ming Yang, Rajiv Agarwal

Second Xiangya Hospital of Central South University; Richard L. Roudebush VA Medical Center

Nephrology, Dialysis, Transplantation, 8 Aug 2026

doi.org/10.1093/ndt/gfag179 PubMed 42570222

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance